Skip to main content

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

 


The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years. Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market.

Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop resilience, and creating environmentally friendly industrial processes. Innovations like gene editing, synthetic biology, and regenerative medicine continue to expand biotechnology’s applications, addressing global challenges in medicine, food security, and sustainable resource management.

Unlock key findings! Fill out a quick inquiry to access a sample report
https://meditechinsights.com/biotechnology-market/request-sample/

Advancements in genetic engineering and genomics to propel market demand

Advancements in genetic engineering and genomics are significantly propelling the biotechnology market by enabling precise modifications at the genetic level, fostering breakthroughs in personalized medicine, gene therapies, and biopharmaceuticals. Techniques like CRISPR-Cas9 and next-generation sequencing (NGS) have transformed disease treatment and prevention, allowing for targeted therapies that cater to individual genetic profiles. These innovations support the development of therapies for previously untreatable diseases and improve crop resilience in agriculture. Additionally, genomics-based data analytics facilitate faster drug discovery and development processes, reducing R&D costs and time-to-market. This precision and efficiency are attracting substantial investments across the biotechnology sector.

Growing demand for biopharmaceuticals is driving the market growth

The growing demand for biopharmaceuticals is a major driver of biotechnology market growth, as biologic drugs like monoclonal antibodies, vaccines, and cell therapies offer targeted treatments with fewer side effects compared to traditional medications. Biopharmaceuticals are particularly effective in treating complex chronic diseases, including cancer, autoimmune disorders, and genetic conditions. Their efficacy and specificity are fueling global demand, prompting biopharma companies to expand R&D investments. Additionally, advancements in biotechnology, such as recombinant DNA technology and advanced bio-manufacturing processes, enable efficient biopharmaceutical production, supporting rapid market expansion and the development of more personalized, high-impact therapies.

Get exclusive insights - download your sample report today 
https://meditechinsights.com/biotechnology-market/request-sample/

Competitive Landscape Analysis

The global biotechnology market is marked by the presence of established and emerging market players such as F. Hoffmann-La Roche Ltd, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Novartis AG, Biogen, Abbott, Pfizer Inc., Amgen Inc., Novo Nordisk A/S, and Merck KGaA; among others. Some of the key strategies adopted by market players include new product and service development, strategic partnerships and collaborations, and geographic expansion.

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more

Global Structural Heart Devices Market growth 9% CAGR with favorable reimbursement scenarios 2030

  The global structural heart devices market is set to witness a CAGR of ~9% in the next 5 years.  The rising geriatric population & corresponding rise in the prevalence of heart disease, technological advancements in structural heart devices, regulatory approval for expanded indications for several transcatheter heart valves, and increasing awareness and favorable reimbursements for these procedures in key markets are some of the pivotal factors driving the growth of the structural heart devices market. However, high device costs, complex procedures, and stringent regulatory hurdles continue to restrain market uptake.  Structural heart disease occurs when something is wrong with one’s heart valves, walls, chambers or muscles. It exists from birth or develops as one age. It includes conditions such as congenital heart disease, cardiomyopathy, and heart valve disease. Heart valve devices, occluders & delivery systems, annuloplasty rings, heart access systems, cl...
Post a Comment
Read more